| Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes (NCT00365170) | Novo Nordisk A/S | 2002-09-01 |
| Diabetes Management Personal Trainer (NCT00340093) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-08-23 |
| Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes (NCT01467401) | Novo Nordisk A/S | 2002-08-19 |
| Gene Therapy to Improve Wound Healing in Patients With Diabetes (NCT00065663) | Tissue Repair Company | 2002-08-01 |
| Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes (NCT00312156) | Novo Nordisk A/S | 2002-08-01 |
| Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes (NCT01511172) | Novo Nordisk A/S | 2002-08-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes (NCT01542450) | Novo Nordisk A/S | 2002-08-01 |
| Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes (NCT01720290) | Novo Nordisk A/S | 2002-07-25 |
| Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01697631) | Novo Nordisk A/S | 2002-07-22 |
| Metformin & Inflammation in Pre-diabetic Children (NCT01394887) | Coordinación de Investigación en Salud, Mexico | 2002-07-01 |
| Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein (NCT00221715) | University Hospital, Bordeaux | 2002-07-01 |
| Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes (NCT01467141) | Novo Nordisk A/S | 2002-06-19 |
| Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population (NCT00071448) | Novo Nordisk A/S | 2002-06-01 |
| Hyperbaric Oxygen Therapy as Adjunctive Treatment of Chronic Diabetic Foot Ulcers (NCT00953186) | Mrs. Thelma Zoegas Foundation | 2002-06-01 |
| Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01487798) | Novo Nordisk A/S | 2002-06-01 |
| Shear and Pressure Reducing Insoles for the Diabetic Foot (NCT00499356) | Diabetica Solutions Inc. | 2002-05-01 |
| Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes (NCT01526980) | Novo Nordisk A/S | 2002-05-01 |
| Efficacy of Repaglinide in Subjects With Type 2 Diabetes (NCT01698931) | Novo Nordisk A/S | 2002-04-26 |
| Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes (NCT00312104) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey of Production of Insulin Aspart Specific Antibody (NCT01487369) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey for Paediatric Subjects (NCT01487382) | Novo Nordisk A/S | 2002-04-01 |
| Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter Syndrome (NCT00523835) | University of Aarhus | 2002-04-01 |
| Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy (NCT00903851) | Endo USA Inc., a Keenova Therapeutics Company | 2002-04-01 |
| Special Survey for Type 1 or Type 2 Diabetic Patients (NCT01487408) | Novo Nordisk A/S | 2002-04-01 |
| A Randomized Trial of Electronic Integration of Care for Better Diabetes Outcomes; The COMPETE II Study (NCT00813085) | McMaster University | 2002-04-01 |
| Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes (NCT01486381) | Novo Nordisk A/S | 2002-03-20 |
| Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes (NCT01465152) | Novo Nordisk A/S | 2002-03-06 |
| Safety and Efficacy of Insulin Aspart in Type 2 Diabetes (NCT01649570) | Novo Nordisk A/S | 2002-03-01 |
| Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes (NCT01486940) | Novo Nordisk A/S | 2002-03-01 |
| Fibre and Appetite Regulation Trial (FART) (NCT00247455) | University of Toronto | 2002-03-01 |
| Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes (NCT00676819) | Novo Nordisk A/S | 2002-01-10 |
| Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus (NCT00057317) | Hoffmann-La Roche | 2001-12-01 |
| Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes (NCT01527539) | Novo Nordisk A/S | 2001-11-23 |
| Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes (NCT01605773) | Novo Nordisk A/S | 2001-11-08 |
| Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers (NCT01511159) | Novo Nordisk A/S | 2001-10-01 |
| Gender Differences in Prevalence of Undiagnosed Diabetes in ACS (NCT00589459) | Yale University | 2001-10-01 |
| Research Study in Patients With Persistent Macular Edema (NCT00035906) | Allergan | 2001-10-01 |
| Patient Provider Partnership: Improving Diabetes Care in the Community (NCT00167284) | University of Pittsburgh | 2001-10-01 |
| Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes (NCT01697657) | Novo Nordisk A/S | 2001-09-01 |
| Observational Study of NovoNorm® in Subjects With Diabetes (NCT01498913) | Novo Nordisk A/S | 2001-08-30 |
| TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study (NCT03272854) | University Medical Center Groningen | 2001-08-01 |
| Diabetes Health Enhancement Program to Improve Health of People With Diabetes (NCT00291590) | Robert Wood Johnson Foundation | 2001-07-01 |
| Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes (NCT01562561) | Novo Nordisk A/S | 2001-06-01 |
| Look AHEAD: Action for Health in Diabetes (NCT00017953) | Wake Forest University Health Sciences | 2001-06-01 |
| Effects of Human Leptin Replacement (NCT00657605) | University of Miami | 2001-06-01 |
| Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes (NCT01508949) | Novo Nordisk A/S | 2001-06-01 |
| Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01526941) | Novo Nordisk A/S | 2001-05-01 |
| Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes (NCT01508923) | Novo Nordisk A/S | 2001-05-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes (NCT01704378) | Novo Nordisk A/S | 2001-04-18 |
| Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes (NCT01509742) | Novo Nordisk A/S | 2001-04-01 |
| Life Style Modifications Prevents Type 2 Diabetes in Asian Indians (NCT00279240) | M.V. Hospital for Diabetes | 2001-03-01 |
| Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent (NCT01511198) | Novo Nordisk A/S | 2001-02-01 |
| Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group (NCT01511185) | Novo Nordisk A/S | 2001-02-01 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes (NCT01620424) | Novo Nordisk A/S | 2001-02-01 |
| A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes (NCT00400283) | Novo Nordisk A/S | 2001-01-19 |
| Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01467375) | Novo Nordisk A/S | 2001-01-08 |
| Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01524809) | Novo Nordisk A/S | 2001-01-01 |
| Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes (NCT01650129) | Novo Nordisk A/S | 2000-12-13 |
| The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients (NCT00571818) | University of Nebraska | 2000-11-01 |
| Regulation of Hepatic Insulin Extraction (NCT00811044) | Washington University School of Medicine | 2000-10-01 |
| Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes (NCT01509755) | Novo Nordisk A/S | 2000-10-01 |
| Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants (NCT00288977) | Beth Israel Deaconess Medical Center | 2000-09-01 |
| Evaluation of Programs of Coordinated Care and Disease Management (NCT00627029) | Mathematica Policy Research, Inc. | 2000-09-01 |
| Differential Metabolism of Dietary Fatty Acids (NCT00059254) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-09-01 |
| Improving Diabetes Care Collaboratively in the Community (NCT00359996) | University of Chicago | 2000-06-01 |
| TempTouch IR Thermometry & Diabetic Patient Self-Care (NCT00289497) | Diabetica Solutions Inc. | 2000-06-01 |
| Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults (NCT00331448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes (NCT00065130) | Novo Nordisk A/S | 2000-04-01 |
| Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes (NCT01520818) | Novo Nordisk A/S | 2000-03-01 |
| Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers (NCT01620333) | Novo Nordisk A/S | 2000-02-01 |
| Food Intake and Appetite in the Children of Mothers With Diabetes (NCT00339313) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-01-12 |
| Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes (NCT00832182) | Novo Nordisk A/S | 1999-12-22 |
| Comparison of Two Formulations of Biphasic Insulin Aspart 70 (NCT01523041) | Novo Nordisk A/S | 1999-11-03 |
| The Family Investigation of Nephropathy and Diabetes Study (NCT00301249) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-10-01 |
| A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin (NCT02162407) | Novo Nordisk A/S | 1999-10-01 |
| Improving Compliance With Metformin (NCT00018616) | US Department of Veterans Affairs | 1999-10-01 |
| Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes (NCT01507311) | Novo Nordisk A/S | 1999-09-01 |
| Effect of Olive Leaves as Hypoglycemic Agents in Diabetic Subjects (NCT01427998) | Wolfson Medical Center | 1999-08-01 |
| Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes (NCT01507285) | Novo Nordisk A/S | 1999-08-01 |
| Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects (NCT01520831) | Novo Nordisk A/S | 1999-04-01 |
| Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans (NCT00018486) | US Department of Veterans Affairs | 1999-04-01 |
| Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes (NCT01520753) | Novo Nordisk A/S | 1999-03-01 |
| Safety and Tolerability of Liraglutide in Healthy Male Volunteers (NCT01507272) | Novo Nordisk A/S | 1999-03-01 |
| Effect of Chronic PDE5-Inhibition on Endothelial Function in Diabetics (NCT00420901) | IRCCS San Raffaele | 1999-01-01 |
| Diabetes and Heart Disease Risk in Blacks (NCT00001853) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-10-21 |
| Metabolic Adaptations to Diabetes in African Americans (NCT00780195) | Vanderbilt University | 1998-07-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes (NCT01467323) | Novo Nordisk A/S | 1998-04-01 |
| Preventing Depression Recurrence in Diabetes (NCT00374426) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-03-01 |
| Comparison of 2 NovoFine® Needles on the Reflux of Insulin (NCT00872560) | Novo Nordisk A/S | 1998-01-20 |
| Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes (NCT01707134) | Novo Nordisk A/S | 1997-09-01 |
| Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles (NCT00871416) | Novo Nordisk A/S | 1997-04-09 |
| Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01697618) | Novo Nordisk A/S | 1997-04-01 |
| A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) (NCT00235014) | Abbott | 1997-03-01 |
| Clinical Trial of Footwear in Patients With Diabetes (NCT00032864) | US Department of Veterans Affairs | 1997-01-01 |
| Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus (NCT00339885) | National Human Genome Research Institute (NHGRI) | 1996-06-01 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers (NCT01707160) | Novo Nordisk A/S | 1995-11-01 |
| Family-Centered Diabetes Project (NCT00006159) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1994-03-01 |
| The Singapore Chinese Health Study (NCT03356340) | Duke-NUS Graduate Medical School | 1993-04-01 |
| Stroke Incidence and Risk Factors in a Tri-ethnic Region (NCT03266952) | University of Miami | 1993-01-01 |
| Fernald Community Cohort -18 Year Observational Study (NCT02295085) | University of Cincinnati | 1990-09-01 |